1,336 results on '"Soriano, E."'
Search Results
2. Synthesis, photophysical properties and nonlinear response of a bisquinoline A-D-A with aggregation-induced emission for potential application in optoelectronic devices
3. POS0249 ASSOCIATIONS BETWEEN CLINICAL CHARACTERISTICS AND SCREENING MRI FINDINGS: EXPLORATORY ANALYSIS OF THE ONGOING PHASE 4, MULTICENTER, RANDOMIZED, CONTROLLED STAR STUDY OF BIOLOGIC-NAÏVE PATIENTS WITH PsA WITH MRI-CONFIRMED AXIAL INVOLVEMENT
4. AB1633-HPR LATIN AMERICAN RHEUMATOLOGIST AWARENESS AND PERCEPTION OF FIBROMYALGIA - FIBROLATAM SURVEY
5. Advanced interatrial block predicts recurrence of embolic stroke of undetermined source
6. El bloqueo interatrial avanzado predice recurrencia de infarto cerebral embólico de origen no determinado
7. Towards standardized patient reported physical function outcome reporting : linking ten commonly used questionnaires to a common metric
8. Effectiveness of the use of an algorithm in the diagnostic approach of joint pain patients by primary care physicians
9. Quantification of Expected Changes in Peak Flow Quantiles in Climate Change by Combining Continuous Hydrological Modelling with the Modified Curve Number Method
10. Hidden Costs in the Physiology of Argia anceps (Zigoptera: Coenagrionidae) due to Pollution
11. Deep surgical site infection following thoracolumbar instrumented spinal surgery. Ten years of experience
12. Infección quirúrgica profunda en cirugía instrumentada de raquis toracolumbar. Diez años de experiencia
13. Synthesis, photophysical properties and nonlinear response of a Bisquinoline A-D-A with aggregation-induced emission for potential application in optoelectronic devices
14. Towards standardized patient reported physical function outcome reporting: linking ten commonly used questionnaires to a common metric
15. Silica-based nanocatalysts in the C[sbnd]C and C-heteroatom bond forming cascade reactions for the synthesis of biologically active heterocyclic scaffolds
16. Executive Retreat: proceedings of the GRAPPA Executive Retreat 2022
17. Design of a Low-Cost Manipulator Arm for Industrial Fields
18. Species Richness and Abundance of Cerambycidae (Coleoptera) in Huatulco, Oaxaca, Mexico; Relationships with Phenological Changes in the Tropical Dry Forest
19. POS0974 CARDIOVASCULAR OUTCOMES OF ANTI-TNF ALFA AND JAK INHIBITORS IN PATIENTS WITH RHEUMATOID AND PSORIATIC ARTHRITIS. REAL WORLD EVIDENCE AND INSIGHTS OF BIOBADASAR 3.0 REGISTRY
20. AB1088 EARLY CLINICAL IMPROVEMENT AS PREDICTOR OF LONG-TERM HEALTH-RELATED QUALITY OF LIFE IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH GUSELKUMAB: POST-HOC ANALYSIS THROUGH 2 YEARS OF A PHASE-3 STUDY
21. AB1094 GUSELKUMAB EFFECT ON INFLAMMATORY CARDIOVASCULAR (CV) RISK BIOMARKERS, EFFICACY, AND SAFETY IN PSORIATIC ARTHRITIS PATIENTS WITH CV RISK FACTORS: POST-HOC ANALYSIS OF 2 PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES
22. AB1582 DEPRESSION IN RHEUMATOLOGIST FROM LATIN AMERICA
23. POS0023 PERFORMANCE OF BASDAI VS. ASDAS IN EVALUATING AXIAL INVOLVEMENT IN PATIENTS WITH PSA TREATED WITH GUSELKUMAB: POOLED ANALYSIS OF TWO PHASE 3 STUDIES
24. AB1093 LONG-TERM IMPROVEMENT IN INDIVIDUAL ACR RESPONSE CRITERIA AND RESIDUAL DISEASE IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH GUSELKUMAB: POST HOC ANALYSIS OF A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
25. AB1666 CLUSTER ANALYSIS TO IDENTIFY PATIENT GROUPS AND ASSESS THE PRESENCE OF ADVERSE EVENTS. REAL WORLD EVIDENCE FROM THE BIOBADASAR 3.0 REGISTRY
26. AB1095 IMPACT OF PSORIATIC ARTHRITIS MANIFESTATIONS ON PERCEPTION OF PAIN IMPROVEMENT: POOLED ANALYSIS OF TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES WITH GUSELKUMAB
27. AB1084 GUSELKUMAB PROVIDES RAPID CLINICALLY MEANINGFUL IMPROVEMENTS IN CLINICAL AND PATIENT REPORTED OUTCOMES AND SUSTAINED DISEASE CONTROL OF PSORIATIC ARTHRITIS
28. POS1535 EARLY IMPROVEMENT IN 3VAS/4VAS PREDICTS REDUCED RATES OF RADIOGRAPHIC CHANGE IN BIO-NAIVE ACTIVE PSORIATIC ARTHRITIS PATIENTS RECEIVING GUSELKUMAB TREATMENT
29. AB1108 EFFECT OF GUSELKUMAB ADMINISTERED EVERY 8 WEEKS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS PERSISTS BETWEEN CONSECUTIVE DOSES AND IS DURABLE: POST HOC ANALYSIS OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
30. POS0228 MINIMAL IMPORTANT DIFFERENCE (MID), MINIMAL DETECTABLE CHANGE (MDC), AND DISEASE ACTIVITY THRESHOLDS FOR TWO NOVEL COMPOSITE INSTRUMENTS (3VAS, 4VAS) IN PATIENTS WITH PSORIATIC ARTHRITIS: POOLED ANALYSIS OF THREE PHASE 3 STUDIES
31. AB1655 PREVALENCE OF COMORBIDITIES IN RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND AXIAL SPONDYLARTHRITIS: RESULTS OF AN INTERNATIONAL, REAL WORLD PANLAR´S REGISTER
32. AB0620 IMMUNE THROMBOCYTOPENIC PURPURA AND SUBSEQUENT DEVELOPMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS
33. P051 - Suivi gynécologique de prévention et santé sexuelle: comparaison entre personnes sourdes et entendantes
34. Models for Determining the Static Stiffness of Collet Sleeves
35. Service-Learning Projects Based on Dynamic Documentation in Engineering Colleges
36. Hypervulnerability of the adolescent prefrontal cortex to nutritional stress via reelin deficiency
37. Historical context of commercial exploitation of seaweeds in Brazil
38. Analysis of the Clamping Mechanisms of Collet-Chucks Holders for Turning
39. Amphipod choice for seaweeds under predator cues: interactions on decision-making behavior
40. Defense response in bean roots is not affected by low phosphate nutrition
41. Bifunctional mesoporous MCF materials as catalysts in the Friedländer condensation
42. Studying sporadic and familial Alzheimer's disease on iPSC-derived hippocampal and cortical neurons: effect of APOE and Presenilin1
43. Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer’s disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids
44. P-050 Reproductive results in vasectomized patients according to the time of the surgical procedure
45. Axon Guidance and Repulsion. The Molecular Code of Social Life in the Brain
46. Amino-grafted mesoporous materials based on MCF structure involved in the quinoline synthesis. Mechanistic insights
47. Risk of severe COVID-19 associated with immune-modifying drugs: Data from PsoProtect and Global Rheumatology Alliance registries.
48. POS0660 SURVIVAL AND SAFETY OF BIOLOGICAL AND TARGETED SYNTHETIC THERAPIES. 10 YEARS OF REAL-LIFE DATA. BIOABASAR 3.0 REGISTRY
49. POS0025 PREVALENCE OF ATTENTION DEFICIT HYPERACTIVITY DISORDER AMONG ADULT PATIENTS WITH FIBROMYALGIA
50. OP0249 CHARACTERISTICS ASSOCIATED WITH POOR COVID-19 OUTCOMES IN PEOPLE WITH PSORIASIS AND SPONDYLOARTHRITIS: DATA FROM THE COVID-19 PsoProtect AND GLOBAL RHEUMATOLOGY ALLIANCE PHYSICIAN-REPORTED REGISTRIES
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.